AI Beat

TechHealth

Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trials

Image: TechCrunch

Isomorphic Labs, an AI drug-discovery platform spun out of Google DeepMind in 2021, has raised $5 billion in Series C funding. The capital will accelerate the company's pipeline of drug candidates toward clinical trials.

Why it matters

The massive funding round demonstrates investor confidence in AI-driven drug discovery and brings computational approaches to pharmaceutical development closer to real-world testing.

More on:Google DeepMind

Coverage